ecrin-mdr-crcClinical1999Colorectal AdenomaAdenomaColorectal AdenomaAdenomaInterventionalhttps://newmdr.ecrin.org/Study/202566212RofecoxibECRIN MDRCompletedfalseA Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)This study was to compare the effect of 156 weeks of treatment with MK-0966 (Rofecoxib) versus placebo on the recurrence of colorectal adenomas (growths that occur on the inside (the lining) of the large intestine, also known as the colon) in patients with a history of colorectal adenomas.1999-12-152025662NCT00282386